论文信息 - Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials - 字舞流文

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

D. Cooper | M. Youle | R. Leavitt | A. Rodgers | J. Eron | G. Fätkenheuer | D. Berger | B. Nguyen | C. Workman | E. Dejesus | M. Dinubile | B. Young | Richard J. O. Barnard | J. Andrade-Villanueva | R. Zajdenverg | Princy N. Kumar | P. Sklar | Xia Xu | M. Shaughnessy | Monica L Walker | M. Miller | Michael D. Miller